---
title: "Durlax Top Surface Ltd (DURLAX) — Share Price, Financials & Analysis"
symbol: "DURLAX"
company: "Durlax Top Surface Ltd"
canonical: "https://tapetide.com/stocks/DURLAX"
isin: "INE0OUW01013"
nse_symbol: "DURLAX"
sector: "Consumer Goods"
industry: "Home Furnishing"
market_cap_cr: 176.49
generated_at: "2026-09-13T19:10:11.157Z"
---

# Durlax Top Surface Ltd (DURLAX)

Canonical page: https://tapetide.com/stocks/DURLAX

## Company

- **NSE Symbol:** DURLAX
- **ISIN:** INE0OUW01013
- **Sector:** Consumer Goods
- **Industry:** Home Furnishing
- **Macro Sector:** Consumer Discretionary
- **Stock Type:** EQUITY
- **Listed Since:** 2024-06-26
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** durlax.com

## About

Established in 2010, Durlax Top Surface Limited manufactures solid surface materials.[1]

## Latest Price

- **Price:** ₹60.95
- **Change:** -0.5 (-0.81%)
- **Open:** ₹60
- **Day High:** ₹63.45
- **Day Low:** ₹59.55
- **Previous Close:** ₹61.45
- **Volume:** 88000
- **As Of:** 2026-09-11T09:58:10+00:00

## Key Fundamentals

Observed at 2026-09-11T04:43:17.534461Z.

- **Market Cap:** ₹176.49 Cr
- **Classification:** SME
- **P/E (reported):** 12.5
- **Book Value:** ₹40.27
- **Price to Book:** 1.53
- **Dividend Yield:** 0%
- **ROE:** 10.84%
- **ROCE:** 18.05%
- **Debt to Equity:** 0.34
- **Revenue (yearly):** ₹186.9 Cr
- **Net Income:** ₹12.6 Cr
- **EBITDA:** ₹24.8 Cr
- **52-Week High:** ₹72
- **52-Week Low:** ₹30.55
- **RSI (14):** 48.94

## Tapetide Score

- **Score:** 62 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Fair · Momentum: Rising
- **Percentile:** 92.5 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 69.43 | 9% |
| growth | 92.05 | 9% |
| momentum | 97.75 | 12% |
| ownership | 51.65 | 24% |
| quality | 50.12 | 22% |
| valuation | 52.68 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 77.2% CAGR over last 5 years

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -82.3% | 25.54% | -907.84% |
| ebitda margin growth | -54.48% | 2.55% | 8.59% | -5.48% |
| net income growth | -65.85% | 68% | 70% | 77% |
| revenue growth | -24.84% | 49.76% | 40% | 57% |
| roce | — | -14.45% | -1.69% | 17.76% |
| roe | — | -16.62% | 14.1% | 66.51% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- |
| Sales | 29.59 | 76.81 | 55.99 |
| Expenses | 26.17 | 65.59 | 53.27 |
| Operating Profit | 3.42 | 11.22 | 2.72 |
| OPM % | 11.56 | 14.61 | 4.86 |
| Other Income | 0.03 | 2.13 | 3.34 |
| Interest | 1.03 | 1.19 | 1.28 |
| Depreciation | 0.61 | 0.7 | 1.06 |
| Profit before tax | 1.81 | 11.46 | 3.72 |
| Tax % | 29.83 | 28.62 | 26.08 |
| Net Profit | 1.26 | 8.19 | 2.75 |
| EPS in Rs | 0.44 | 2.83 | 0.95 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 30 | 20 | 47 | 67 | 91 | 123 | 185 |
| Expenses | 26 | 15 | 41 | 59 | 80 | 109 | 162 |
| Operating Profit | 5 | 5 | 7 | 8 | 11 | 14 | 22 |
| OPM % | 15 | 24 | 14 | 12 | 12 | 11 | 12 |
| Other Income | 0 | 0 | 0 | 0 | -1 | 2 | 2 |
| Interest | 3 | 3 | 3 | 3 | 4 | 4 | 5 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | -1 | 0 | 1 | 3 | 4 | 10 | 18 |
| Tax % | 83 | 1125 | 35 | 9 | 3 | 25 | 28 |
| Net Profit | -1 | -1 | 1 | 3 | 4 | 8 | 13 |
| EPS in Rs | -36 | -27.67 | 27 | 1.22 | 1.85 | 2.6 | 4.37 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.15 | 0.15 | 0.15 | 12 | 12 | 17 | 29 |
| Reserves | 12 | 11 | 12 | 4 | 9 | 41 | 88 |
| Borrowings | 32 | 37 | 39 | 37 | 61 | 46 | 40 |
| Other Liabilities | 13 | 9 | 20 | 24 | 23 | 11 | 18 |
| Total Liabilities | 58 | 58 | 72 | 78 | 106 | 115 | 175 |
| Fixed Assets | 26 | 24 | 22 | 20 | 20 | 18 | 29 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 31 | 33 | 50 | 57 | 85 | 96 | 146 |
| Total Assets | 58 | 58 | 72 | 78 | 106 | 115 | 175 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | -3 | 2 | 4 | -17 | -7 | -12 |
| Cash from Investing Activity | — | 0 | 0 | 0 | -4 | -4 | -13 |
| Cash from Financing Activity | — | 3 | -1 | -4 | 21 | 10 | 40 |
| Net Cash Flow | — | 0 | 0 | 0 | 0 | 0 | 14 |
| Free Cash Flow | — | -3 | 2 | 4 | -20 | -7 | -25 |
| CFO/OP | — | -63 | 23 | 52 | -150 | -38 | -43 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 75 | 95 | 125 | 87 | 121 | 104 | 127 |
| Inventory Days | 277 | 759 | 300 | 266 | 253 | 186 | 105 |
| Days Payable | 215 | 196 | 178 | 144 | 110 | 31 | 23 |
| Cash Conversion Cycle | 137 | 658 | 247 | 209 | 264 | 260 | 209 |
| Working Capital Days | -2 | 241 | 70 | 73 | 81 | 122 | 145 |
| ROCE % | — | 6 | 9 | 12 | 13 | 15 | 17 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Jun 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 95.24% | 95.24% | 60.38% | 60.39% | 60.57% | 51.45% | 51.45% |
| FIIs | 0% | 0% | 1.24% | 0% | 0% | 0.85% | 0.92% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 0% | 32.32% | 32.78% | 32.1% | 36.49% | 41.12% |
| Others | 4.76% | 4.76% | 6.06% | 6.83% | 7.33% | 11.21% | 6.52% |
| No. of Shareholders | 21 | 21 | 1683 | 1460 | 1378 | 1446 | 1673 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 3 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 63.77 | Sell |
| EMA (10) | 63.33 | Sell |
| SMA (20) | 64.02 | Sell |
| EMA (20) | 62.75 | Sell |
| SMA (50) | 57.31 | Buy |
| EMA (50) | 59.08 | Buy |
| SMA (100) | 54.69 | Buy |
| EMA (100) | 55.14 | Buy |
| SMA (200) | 47.9 | Buy |
| EMA (200) | 50.66 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 47.81 | Neutral |
| MACD (12,26,9) | 1.39 | Sell |
| Stochastic (14,3,3) | 18.27 | Buy |
| ADX (14) | 32.95 | Buy |
| Williams %R (14) | -85.19 | Buy |
| ATR (14) | 3.65 | High Volatility |
| ROC (12) | -10.43 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 57.59 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 May 2026 - Board meeting on May 9, 2026 cancelled; audited FY26 results date to be announced later. | [General Updates 9 May 2026 - Board meeting on May 9, 2026 cancelled; audited FY26 results date to be announced later.](https://nsearchives.nseindia.com/corporate/DURLAX_09052026171645_postponeofBM.pdf) |
| 9 March 2026 - Corrigendum: Rights Issue agreement dates corrected to December 11, 2025 (was December 16, 2025). | [General Updates 9 March 2026 - Corrigendum: Rights Issue agreement dates corrected to December 11, 2025 (was December 16, 2025).](https://nsearchives.nseindia.com/corporate/DURLAX_09032026194016_Regulation_30_Outcome_Signed_2026-03-09.pdf) |
| 7 March 2026 - Allotted 12,304,497 rights shares at ₹40 each; paid-up capital increased to 2,89,32,198 (06-Mar-2026). | [General Updates 7 March 2026 - Allotted 12,304,497 rights shares at ₹40 each; paid-up capital increased to 2,89,32,198 (06-Mar-2026).](https://nsearchives.nseindia.com/corporate/DURLAX_07032026203106_Outcome.pdf) |
| 5 March 2026 - Rights issue of up to ₹4,921.80 Lakhs opened Feb 23, 2026, closed Mar 05, 2026. | [General Updates 5 March 2026 - Rights issue of up to ₹4,921.80 Lakhs opened Feb 23, 2026, closed Mar 05, 2026.](https://nsearchives.nseindia.com/corporate/DURLAX_05032026172623_Reg_30_Intimation_of_Closure_of_Issue.pdf) |
| 5 June 2026 - Shravan Suthar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | [Disclosure under SEBI Takeover Regulations 5 June 2026 - Shravan Suthar has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.](https://nsearchives.nseindia.com/corporate/team_bbodade_25052026164629_DURLAX.pdf) |
| 3 April 2026 - CFO Kalpana Mogal Nikam resigned; effective end of May 2, 2026. | [General Updates 3 April 2026 - CFO Kalpana Mogal Nikam resigned; effective end of May 2, 2026.](https://nsearchives.nseindia.com/corporate/DURLAX_03042026162211_directorsreportwithMDAreport_2025.pdf) |
| 29 Jun - Trading window closed from 1 July 2026 until 48 hours after Q1 FY2027 results. | [Trading Window 29 Jun - Trading window closed from 1 July 2026 until 48 hours after Q1 FY2027 results.](https://nsearchives.nseindia.com/corporate/DURLAX_29062026133435_Trading_Window_Closure.pdf) |
| 26 May 2026 - Board approved FY26 audited standalone results; rights issue proceeds utilised ₹39.71 crore, no deviation. | [Updates 26 May 2026 - Board approved FY26 audited standalone results; rights issue proceeds utilised ₹39.71 crore, no deviation.](https://nsearchives.nseindia.com/corporate/DURLAX_26052026131735_outcomeofBM2152026.pdf) |
| 26 March 2026 - Trading window closed from 1 April 2026 until 48 hours after FY2026 results; board date to be notified. | [Trading Window 26 March 2026 - Trading window closed from 1 April 2026 until 48 hours after FY2026 results; board date to be notified.](https://nsearchives.nseindia.com/corporate/DURLAX_26032026122949_Trading_Window.pdf) |
| 26 Jun - Board allotted 1.03 crore convertible warrants at Rs47.50, aggregating Rs49 crore, to promoters and others. | [General Updates 26 Jun - Board allotted 1.03 crore convertible warrants at Rs47.50, aggregating Rs49 crore, to promoters and others.](https://nsearchives.nseindia.com/corporate/DURLAX_26062026225348_Durlax_Reg_30_Allotment_of_Warrants.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_30971_DURLAX_2025_2026_A_3631032_01092026140423.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28155_DURLAX_2024_2025_A_2280253_02092025164909.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25119_DURLAX_2023_2024_24082024141212.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:10:11.157Z.